The latest closing stock price for Entrada Therapeutics as of September 19, 2024 is 15.00.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-374 today, roughly 0 times their original investment - a -14.44% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 18.17, which is 21.1% above the current share price.
The Entrada Therapeutics 52-week low stock price is 10.75, which is 28.3% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 14.74.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-374 today, roughly 0 times their original investment - a -14.44% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 18.17, which is 21.1% above the current share price.
The Entrada Therapeutics 52-week low stock price is 10.75, which is 28.3% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 14.74.